Drug products: Fucidin, Fucidin®, Fucidin®-Hydrocortison, Fucidine, Fucidin-Hydrocortison, Fucithalmic, Fucithalmic®, Fusidinsyra/Betametason Ebb, Fusidinsyra/Betametason LEO, Fusidinsyra/Hydrokortison 2care4
ATC code: D06AX01, D07CA01, D07CC01, S01AA13
Published controlled studies on differences between men and women on efficacy, safety and pharmacokinetics for topical fusidic acid are lacking.
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of topical fusidic acid have been found.
No studies with a clinically relevant sex analysis regarding the effects of topical fusidic acid have been found.
No studies with a clinically relevant sex analysis regarding adverse effects of topical fusidic acid have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
A retrospective analysis of patients with eczema or psoriasis on standard dermatological treatment (295 men, 291 women) found that significantly more men than women (79; 63%, 47; 37%) were administered whole-body UV treatment. Also, the results indicated that men had more treatments appointments per individual than women. Women were prescribed more emollients than men .
Date of litterature search: 2022-06-29
Reviewed by: Diana Rydberg
Approved by: Karin Schenck-Gustafsson